CN108902990A - A kind of Low lactose milk formula powder and preparation method thereof - Google Patents
A kind of Low lactose milk formula powder and preparation method thereof Download PDFInfo
- Publication number
- CN108902990A CN108902990A CN201810620775.7A CN201810620775A CN108902990A CN 108902990 A CN108902990 A CN 108902990A CN 201810620775 A CN201810620775 A CN 201810620775A CN 108902990 A CN108902990 A CN 108902990A
- Authority
- CN
- China
- Prior art keywords
- mixed
- oil
- acid
- formula powder
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008101 lactose Substances 0.000 title claims abstract description 49
- 239000000843 powder Substances 0.000 title claims abstract description 48
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 title claims abstract description 47
- 235000013350 formula milk Nutrition 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 239000003921 oil Substances 0.000 claims abstract description 26
- 235000019198 oils Nutrition 0.000 claims abstract description 26
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 19
- 239000008158 vegetable oil Substances 0.000 claims abstract description 19
- 235000014121 butter Nutrition 0.000 claims abstract description 13
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000006188 syrup Substances 0.000 claims abstract description 12
- 235000020357 syrup Nutrition 0.000 claims abstract description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 11
- 239000008103 glucose Substances 0.000 claims abstract description 11
- 239000005018 casein Substances 0.000 claims abstract description 9
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000021240 caseins Nutrition 0.000 claims abstract description 9
- -1 linoleic acid, alpha-linolenic acid fatty acid Chemical class 0.000 claims abstract description 4
- 239000007788 liquid Substances 0.000 claims description 20
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 18
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 17
- 239000011707 mineral Substances 0.000 claims description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 15
- 239000002994 raw material Substances 0.000 claims description 15
- 239000002131 composite material Substances 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 13
- 229940088594 vitamin Drugs 0.000 claims description 13
- 239000011782 vitamin Substances 0.000 claims description 13
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 12
- 238000001694 spray drying Methods 0.000 claims description 12
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 11
- 239000011734 sodium Substances 0.000 claims description 11
- 229910052708 sodium Inorganic materials 0.000 claims description 11
- 102000007544 Whey Proteins Human genes 0.000 claims description 9
- 108010046377 Whey Proteins Proteins 0.000 claims description 9
- 229940114079 arachidonic acid Drugs 0.000 claims description 9
- 235000021342 arachidonic acid Nutrition 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- NXMUXTAGFPJGTQ-UHFFFAOYSA-N decanoic acid;octanoic acid Chemical compound CCCCCCCC(O)=O.CCCCCCCCCC(O)=O NXMUXTAGFPJGTQ-UHFFFAOYSA-N 0.000 claims description 8
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 8
- 239000003995 emulsifying agent Substances 0.000 claims description 8
- 235000011187 glycerol Nutrition 0.000 claims description 8
- 239000004519 grease Substances 0.000 claims description 8
- 239000003381 stabilizer Substances 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 150000005691 triesters Chemical class 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 235000021119 whey protein Nutrition 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 230000001804 emulsifying effect Effects 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000008213 purified water Substances 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 235000019486 Sunflower oil Nutrition 0.000 claims description 4
- 235000019742 Vitamins premix Nutrition 0.000 claims description 4
- 150000001336 alkenes Chemical class 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 4
- 239000000944 linseed oil Substances 0.000 claims description 4
- 235000021388 linseed oil Nutrition 0.000 claims description 4
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 239000002600 sunflower oil Substances 0.000 claims description 4
- 230000008859 change Effects 0.000 claims description 3
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 claims description 3
- 125000005456 glyceride group Chemical group 0.000 claims description 3
- 239000001508 potassium citrate Substances 0.000 claims description 3
- 229960002635 potassium citrate Drugs 0.000 claims description 3
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 3
- 235000011082 potassium citrates Nutrition 0.000 claims description 3
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims description 2
- 102000002322 Egg Proteins Human genes 0.000 claims description 2
- 108010000912 Egg Proteins Proteins 0.000 claims description 2
- 239000005862 Whey Substances 0.000 claims description 2
- 235000014103 egg white Nutrition 0.000 claims description 2
- 210000000969 egg white Anatomy 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000003549 soybean oil Substances 0.000 claims description 2
- 235000012424 soybean oil Nutrition 0.000 claims description 2
- 239000001334 starch sodium octenyl succinate Substances 0.000 claims description 2
- 235000013826 starch sodium octenyl succinate Nutrition 0.000 claims description 2
- 201000010538 Lactose Intolerance Diseases 0.000 abstract description 13
- 235000013336 milk Nutrition 0.000 abstract description 11
- 210000004080 milk Anatomy 0.000 abstract description 11
- 239000008267 milk Substances 0.000 abstract description 11
- 235000019197 fats Nutrition 0.000 abstract description 10
- DTOSIQBPPRVQHS-PDBXOOCHSA-N (Z,Z,Z)-Octadeca-9,12,15-trienoic acid Natural products CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 abstract description 5
- 150000001720 carbohydrates Chemical class 0.000 abstract description 5
- 235000020661 alpha-linolenic acid Nutrition 0.000 abstract description 3
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 3
- 229930195729 fatty acid Natural products 0.000 abstract description 3
- 239000000194 fatty acid Substances 0.000 abstract description 3
- 229960004488 linolenic acid Drugs 0.000 abstract description 3
- 239000002773 nucleotide Substances 0.000 abstract description 3
- 125000003729 nucleotide group Chemical group 0.000 abstract description 3
- 230000008439 repair process Effects 0.000 abstract description 3
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 abstract description 2
- 102000004407 Lactalbumin Human genes 0.000 abstract description 2
- 108090000942 Lactalbumin Proteins 0.000 abstract description 2
- 150000004665 fatty acids Chemical class 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 238000010237 hybrid technique Methods 0.000 abstract description 2
- 235000019629 palatability Nutrition 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 description 9
- 239000006071 cream Substances 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 102100026189 Beta-galactosidase Human genes 0.000 description 3
- 108010059881 Lactase Proteins 0.000 description 3
- 206010023648 Lactase deficiency Diseases 0.000 description 3
- 235000019482 Palm oil Nutrition 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 108010005774 beta-Galactosidase Proteins 0.000 description 3
- 235000020247 cow milk Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000020256 human milk Nutrition 0.000 description 3
- 210000004251 human milk Anatomy 0.000 description 3
- 229940116108 lactase Drugs 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000002540 palm oil Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 201000009840 acute diarrhea Diseases 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- LKUNXBRZDFMZOK-GFCCVEGCSA-N Capric acid monoglyceride Natural products CCCCCCCCCC(=O)OC[C@H](O)CO LKUNXBRZDFMZOK-GFCCVEGCSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003866 digestant Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- GLCGEJFIZRSXBL-UHFFFAOYSA-N dodeca-1,3,5,7,9,11-hexaene Chemical compound C=CC=CC=CC=CC=CC=C GLCGEJFIZRSXBL-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000020190 lactose-free milk Nutrition 0.000 description 1
- 235000020214 lactose-free milk formula Nutrition 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
- 201000009868 osmotic diarrhea Diseases 0.000 description 1
- 208000028719 osmotic diarrheal disease Diseases 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000020610 powder formula Nutrition 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- LKUNXBRZDFMZOK-UHFFFAOYSA-N rac-1-monodecanoylglycerol Chemical compound CCCCCCCCCC(=O)OCC(O)CO LKUNXBRZDFMZOK-UHFFFAOYSA-N 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Dairy Products (AREA)
Abstract
The present invention provides a kind of Low lactose milk formula powder and preparation method thereof, with the preparation of dry and wet hybrid technique, replace lactose as the source of carbohydrate using glucose syrup, add lactalbumin and casein, ideal aminogram, long-chain fat DHA and ARA are also added other than mixed vegetable oil, middle carbochain fat MCT and short-chain fat butter oil anhydrous butter oil, fatty acid profile is balanced, and the addition of short-chain fat enhances palatability, glutamine is added simultaneously, repair enteron aisle, the present invention contains 0-6 month babies daily required multivitamin and microelement and linoleic acid, alpha-linolenic acid fatty acid, DHA, nucleotide etc., and content meets national standard, lactose content is lower in formula（< 1.0g/100g）, 0-6 month infantile health demands of the Low lactose milk with lactose intolerance are more able to satisfy compared to regular convention formula milk powder, and effectively overcome various shortcoming in the prior art and have high industrial utilization value.
Description
Technical field
The present invention relates to dairy products technical fields, and in particular to a kind of Low lactose milk formula powder and preparation method thereof.
Background technique
Alactasia is the worldwide problem being widely present, the factors such as alactasia and race, heredity, geographical environment
It is related, investigate and find according to Ins of Nutrition & Food Hygiene of Chinese Institute of Preventive Medicine, have in Asians the people of lactose intolerance compared with
More, 3~5 years old when is 36.8% when being 39.0%, 11~13 years old when being 22.1%, 7~8 years old, and adult is more.China is one
The high-incidence country of lactose intolerance, this situation incidence is 75%~95% in Han nationality adults, ethnic group also has 76%~
95.5%, serious lactose intolerance receptor accounts for 20% of crowd or more.
For 0-6 month babies, secondary lactose intolerance is relatively conventional, is usually caused by diarrhea, wherein colyliform
Viral enteritis leads to the incidence highest of secondary lactose intolerance.Infant shows as that borborygmus is active, exhaust increases, abdomen more
It bitterly, is secondly dizziness, loose stools, abdominal distension and diarrhea.Part infant can evolve into unresolved or chronic diarrhea, cause it is malnutritive and
The adverse consequences such as dysplasia.Lactose intolerance benefits from common anti-infectious agent or digestant without obvious curative effects, clinic
On to the 0-6 month babies of acute diarrhea, while treat protopathy, correct diet selection is key.In cow's milk, breast milk
Lactose is the main source of carbohydrate, therefore when the secondary alactasia of acute watery diarrhea, can often it cause carbohydrate in enteric cavity
Interior accumulation causes osmotic diarrhea to make protracted inflammation, continues breast milk or cow milk feeding often aggravates diarrhea, stop breast milk and contain
The intake of lactose food, using Low lactose milk infant formula instead is most simple effective method.Take short-term low-lactose milk powder is auxiliary to control 0-6
A month baby's acute diarrhea, can be such that the course of disease is obviously shortened.Infant is easy to restore normal diet and the state of an illness is without repeatedly, and tracing study is suffered from
Youngster's growth and development is better.Therefore, illustrate low-lactose milk treated powder and pass weight grows to it to the control of new born youngster's diet
It wants, is worth clinical application.
Current existing Low lactose milk formula powder or lactose-free formula powder generally use various method pre-processings and decompose cream
Sugar, to obtain the even lactose-free milk of Low lactose milk.The most common processing method is exactly milk fermentation and addition lactase, cream
The metabolic adsorption of acid in vivo no longer needs the participation of lactase, causes lactose intolerance for milk so Yoghourt compares
Symptom is slight, or lactose is hydrolyzed by adding lactase in cow's milk, reduces lactose content, but when lactose is dense
When degree is down to 0.8% or less, for zymolysis technique, so low concentration of substrate is unfavorable for substrate and reacts with enzyme, it is difficult to
The effect for realizing efficient desugar is one technical barrier of current dairy industry.
Summary of the invention
In view of the foregoing deficiencies of prior art, the purpose of the present invention is to provide a kind of Low lactose milk formula powder and its systems
Preparation Method, a kind of Low lactose milk formula powder, with the preparation of dry and wet hybrid technique, lactose content is lower（< 1.0g/100g）, use Portugal
Grape syrup replaces source of the lactose as carbohydrate, adds lactalbumin and casein, ideal aminogram, in addition to mixed
It closes and also adds long-chain fat DHA and ARA, middle carbochain fat MCT and short-chain fat butter oil anhydrous butter oil outside vegetable oil, fat
Sour spectral balancing, guarantees the adequacy of nutrition, while adding glutamine, repairs enteron aisle.
The present invention provides a kind of Low lactose milk formula powder, it is characterised in that the Low lactose milk formula powder includes following raw material system
At：Concentrated whey protein powder 3%-15%, casein sodium 2%-10%, glucose syrup 60%-75%, mixed vegetable oil 10%-25%, two
Dodecahexaene acid lipid 0.1%-0.5%, Glycerin, mixed triester with caprylic acid capric acid 0.1%-0.5%, arachidonic acid oil 0.1%-0.5% are anhydrous
Cream 0.1%-0.5%；Multi-vitamins 0.1%-0.6%, composite mineral matter 0.4%-2.2%, glutamine 0.1%-1%, described hundred
Divide the mass percent than being Low lactose milk formula powder total mass of raw material；The mixed vegetable oil includes following components：Soybean oil 4%-
15%, palm oil 5%-20%, sunflower oil 4%-15%, linseed oil 0.5%-5.0%, the percentage are mixed vegetable oil raw material
The mass percent of gross mass；The composite mineral matter is 0-6 month baby's mineral substance premixes, and content meets national standard
Sign value requirement；The multi-vitamins are 0-6 month baby's vitamin premixs, and content meets national standard sign value and wants
It asks.
The present invention also provides a kind of preparation methods of Low lactose milk formula powder, it is characterised in that：
Include the following steps：
Base-material preparation（Wet processing）：（1）Concentrated whey protein powder, casein sodium are dissolved in 40 DEG C -50 DEG C of purified water
In, addition glucose syrup, stabilizer are uniformly mixed, and obtain feed liquid A；（2）It is oily mutually to prepare：By mixed vegetable oil and 22 carbon six
After mixing, emulsifier 10- is added in olefin(e) acid grease, arachidonic acid oil, Glycerin, mixed triester with caprylic acid capric acid, anhydrous butter oil
40min, emulsifying temperature are 50-75 DEG C, obtain feed liquid B；（3）Two-phase mixtures：Feed liquid A is mixed with feed liquid B, by shear-mixed
After uniformly, composite mineral matter is added, material C is obtained after high speed shear, sterilization, spray drying, the spray drying is selected from stream
It is dry to change bed, fluidized bed drying temperature is 30 DEG C -40 DEG C；
It is dry-mixed（Dry process）：（4）Multi-vitamins, glutamine are uniformly mixed with material C to get product；
Or include the following steps：
Base-material preparation（Wet processing）：（1）Concentrated whey protein powder, casein sodium are dissolved in 40 DEG C -50 DEG C of purified water
In, addition glucose syrup, stabilizer are uniformly mixed, and obtain feed liquid A；（2）It is oily mutually to prepare：By mixed vegetable oil and 22 carbon six
After mixing, emulsifier 10- is added in olefin(e) acid grease, arachidonic acid oil, Glycerin, mixed triester with caprylic acid capric acid, anhydrous butter oil
40min, emulsifying temperature are 50-75 DEG C, obtain feed liquid B；（3）Two-phase mixtures：Feed liquid A is mixed with feed liquid B, by shear-mixed
After uniformly, material C is obtained after high speed shear, sterilization, spray drying, the spray drying is selected from fluidized bed drying, fluidized bed
Drying temperature is 30 DEG C -40 DEG C；
It is dry-mixed（Dry process）：（4）Multi-vitamins, composite mineral matter, glutamine are uniformly mixed with material C to get production
Product.
Further, the step（1）In stabilizer be selected from 1.0%-2.5% potassium citrate, the percentage be it is low
The mass percent of lactose formula powder total mass of raw material.
Further, the step（2）In emulsifier and its weight be selected from starch Sodium Octenyl Succinate 0.1%-1.5%
Or list diglycerol acid aliphatic ester 0.1%-1.5% or citric acid fatty glyceride 0.1%-1.5%, the percentage are Low lactose milk
The mass percent of formula powder total mass of raw material.
Preferably, the step（3）In sterilization conditions be 68 DEG C -70 DEG C of temperature, time 20-40min；It is spray-dried item
Part is 160 DEG C -210 DEG C of inlet air temperature, 66 DEG C -95 DEG C of temperature of outgoing air.
As described above, a kind of Low lactose milk formula powder and preparation method thereof of the invention, has the advantages that：First,
Lactose is replaced with glucose syrup, avoids infant that secondary lactose intolerance occurs；Second, Fatty acids composition is balanced, except addition is planted
Object oil is outer, also added DHA and ARA, middle carbochain fat MCT and short chain butter oil, butter oil（Anhydrous butter oil）Addition energy
Enough enhance agreeable to the taste sense, and can guarantee nutritional sufficiency；Third adds glutamine in Low lactose milk formula powder, can repair enteron aisle.
Specific embodiment
Embodiments of the present invention are illustrated by particular specific embodiment below, those skilled in the art can be by this explanation
Content disclosed by book is understood other advantages and efficacy of the present invention easily.
Embodiment 1
A kind of Low lactose milk formula powder, the formula powder is by including that following raw material is made：Concentrated whey protein powder 11%, caseinic acid
Sodium 10%, glucose syrup 65%, mixed vegetable oil 10%, docosahexaenoic acid grease 0.1%, arachidonic acid oil 0.1% are pungent
Glycerol decanoate 0.5%, anhydrous butter oil 0.1%；Multi-vitamins 0.6%, composite mineral matter 2.2%, glutamine 1%, the percentage
Than the mass percent for Low lactose milk formula powder total mass of raw material；The mixed vegetable oil includes following components in parts by weight：Greatly
Soya-bean oil 4%, palm oil 5%, sunflower oil 4%, linseed oil 0.5%, the percentage are the quality hundred of mixed vegetable oil gross mass
Divide ratio；The composite mineral matter is 0-6 month baby's mineral substance premixes, and content meets the requirement of national standard sign value；It is described multiple
Closing vitamin is 0-6 month baby's vitamin premixs, and content meets the requirement of national standard sign value.
Embodiment 2
A kind of Low lactose milk formula powder, the formula powder is by including that following raw material is made：Concentrated whey protein powder 15%, caseinic acid
Sodium 10%, glucose syrup 60%, mixed vegetable oil 10%, docosahexaenoic acid grease 0.1%, arachidonic acid oil 0.1%, nothing
Water cream 0.1%, Glycerin, mixed triester with caprylic acid capric acid 0.3%, multi-vitamins 0.1%, composite mineral matter 2.2%, glutamine 1%, the percentage
Than the mass percent for Low lactose milk formula powder total mass of raw material；The mixed vegetable oil includes following components in parts by weight：Greatly
Soya-bean oil 15%, palm oil 20%, sunflower oil 5%, linseed oil 5.0%, the percentage are the quality of mixed vegetable oil gross mass
Percentage；The composite mineral matter is 0-6 month baby's mineral substance premixes, and content meets the requirement of national standard sign value；It is described
Multi-vitamins are 0-6 month baby's vitamin premixs, and content meets the requirement of national standard sign value.
Embodiment 3
A kind of preparation method of Low lactose milk formula powder, includes the following steps：Base-material preparation：（1）Water phase preparation：By condensed whey egg
White powder, casein sodium are dissolved in 40 DEG C of purified water, and addition glucose syrup, stabilizer are uniformly mixed, and obtain feed liquid A；（2）
It is oily mutually to prepare：By mixed vegetable oil and docosahexaenoic acid grease, arachidonic acid oil, Glycerin, mixed triester with caprylic acid capric acid, anhydrous milk
After mixing, emulsifier 40min is added in oil, and emulsifying temperature is 75 DEG C, obtains feed liquid B；（3）Two-phase mixtures：By feed liquid A
It is mixed with feed liquid B, after shear-mixed is uniform, composite mineral matter is added, is obtained after high speed shear, sterilization, spray drying
Material C, the spray drying also include fluidized bed drying, and fluidized bed drying temperature is 30 DEG C；
It is dry-mixed（Dry process）：（4）Multi-vitamins, glutamine are uniformly mixed with material C to get product；
The step（1）In stabilizer be selected from 1.0% potassium citrate.The step（2）In emulsifier be octenyl succinic
Acid-starch sodium 1.5%, single diglycerol acid aliphatic ester 1.5%, citric acid fatty glyceride 1.5%, percentage described above are
The mass percent of Low lactose milk formula powder total mass of raw material.The step（3）In sterilization conditions be 68 DEG C of temperature, the time
20min；Spray drying condition is 160 DEG C of inlet air temperature, 66 DEG C of temperature of outgoing air；The design parameter for the product being prepared：
| Project | Index（Every 100g） |
| Energy（Kilojoule） | 2064 |
| Protein（g） | 10.4 |
| Carbohydrate（g） | 50.4 |
| Fat（g） | 30.6 |
| Lactose（g） | 0.7 |
| DHA（mg） | 43 |
| ARA（mg） | 43 |
| Glutamine（mg） | 98 |
| Alpha-linolenic acid（mg） | 618 |
| Linoleic acid（mg） | 3.3 |
| Sodium（mg） | 185 |
| Potassium（mg） | 535 |
| Copper（ug） | 257 |
| Magnesium（mg） | 35 |
| Iron（mg） | 4.45 |
| Zinc（mg） | 4.78 |
| Manganese（ug） | 49 |
| Calcium（mg） | 455 |
| Phosphorus（mg） | 320 |
| Iodine（ug） | 70 |
| Chlorine（mg） | 316 |
| Selenium（ug） | 15.3 |
| Vitamin A（Ug retinol equivalent） | 391 |
| Vitamin D（ug） | 7.1 |
| Vitamin E（Mg alpha-tocopherol equivalent） | 10.0 |
| Vitamin K1（ug） | 35 |
| Vitamin B1（ug） | 358 |
| Vitamin B2（ug） | 761 |
| Vitamin B6（ug） | 289 |
| Vitamin B12（ug） | 1.72 |
| Vitamin C（mg） | 79 |
| Niacin（ug） | 2510 |
| Folic acid（ug） | 90 |
| Pantothenic acid（ug） | 2810 |
| Biotin（ug） | 11.9 |
| Choline（mg） | 100 |
| Inositol（mg） | 30 |
| Taurine（mg） | 35 |
| L-carnitine（mg） | 9.9 |
| Nucleotide（mg） | 40 |
In conclusion 0-6 months infancy stomach are not yet developed completely, gastrointestinal disturbances ability is weak, wants to the degree easily absorbed
Ask higher, it is higher to the comprehensive requirement of nutrition, therefore formula powder is required higher.A kind of Low lactose milk formula provided by the invention
Powder, containing 0-6 month babies daily required multivitamin and microelement and linoleic acid, alpha-linolenic acid, DHA, ARA,
Nucleotide etc., and content meets national standard, belongs to 0-6 month infant formulas of Low lactose milk, compared to regular convention formula powder (containing cream
Sugar) 0-6 month infantile health demands of Low lactose milk with lactose intolerance are more able to satisfy, and effectively overcome in the prior art
Various shortcoming and have high industrial utilization value.
The above-described embodiments merely illustrate the principles and effects of the present invention, and is not intended to limit the present invention.It is any ripe
The personage for knowing this technology all without departing from the spirit and scope of the present invention, carries out modifications and changes to above-described embodiment.Cause
This, institute is complete without departing from the spirit and technical ideas disclosed in the present invention by those of ordinary skill in the art such as
At all equivalent modifications or change, should be covered by the claims of the present invention.
Claims (5)
1. a kind of Low lactose milk formula powder, it is characterised in that the Low lactose milk formula powder includes that following raw material is made：Condensed whey egg
White powder 3%-15%, casein sodium 2%-10%, glucose syrup 60%-75%, mixed vegetable oil 10%-25%, docosahexaenoic acid
Grease 0.1%-0.5%, Glycerin, mixed triester with caprylic acid capric acid 0.1%-0.5%, arachidonic acid oil 0.1%-0.5%, anhydrous butter oil 0.1%-
0.5%；Multi-vitamins 0.1%-0.6%, composite mineral matter 0.4%-2.2%, glutamine 0.1%-1%, the percentage are low
The mass percent of lactose formula powder total mass of raw material；The mixed vegetable oil includes following components：Soybean oil 4%-15%, palm
Oily 5%-20%, sunflower oil 4%-15%, linseed oil 0.5%-5.0%, the percentage are mixed vegetable oil total mass of raw material
Mass percent；The composite mineral matter is 0-6 month baby's mineral substance premixes, and content meets national standard sign value and wants
It asks；The multi-vitamins are 0-6 month baby's vitamin premixs, and content meets the requirement of national standard sign value.
2. a kind of preparation method of Low lactose milk formula powder, it is characterised in that：
Include the following steps：
Base-material preparation（Wet processing）：（1）Concentrated whey protein powder, casein sodium are dissolved in 40 DEG C -50 DEG C of purified water
In, addition glucose syrup, stabilizer are uniformly mixed, and obtain feed liquid A；（2）It is oily mutually to prepare：By mixed vegetable oil and 22 carbon six
After mixing, emulsifier 10- is added in olefin(e) acid grease, arachidonic acid oil, Glycerin, mixed triester with caprylic acid capric acid, anhydrous butter oil
40min, emulsifying temperature are 50-75 DEG C, obtain feed liquid B；（3）Two-phase mixtures：Feed liquid A is mixed with feed liquid B, by shear-mixed
After uniformly, composite mineral matter is added, material C is obtained after high speed shear, sterilization, spray drying, the spray drying is selected from stream
It is dry to change bed, fluidized bed drying temperature is 30 DEG C -40 DEG C；
It is dry-mixed（Dry process）：（4）Multi-vitamins, glutamine are uniformly mixed with material C to get product；
Or include the following steps：
Base-material preparation（Wet processing）：（1）Concentrated whey protein powder, casein sodium are dissolved in 40 DEG C -50 DEG C of purified water
In, addition glucose syrup, stabilizer are uniformly mixed, and obtain feed liquid A；（2）It is oily mutually to prepare：By mixed vegetable oil and 22 carbon six
After mixing, emulsifier 10- is added in olefin(e) acid grease, arachidonic acid oil, Glycerin, mixed triester with caprylic acid capric acid, anhydrous butter oil
40min, emulsifying temperature are 50-75 DEG C, obtain feed liquid B；（3）Two-phase mixtures：Feed liquid A is mixed with feed liquid B, by shear-mixed
After uniformly, material C is obtained after high speed shear, sterilization, spray drying, the spray drying is selected from fluidized bed drying, fluidized bed
Drying temperature is 30 DEG C -40 DEG C；
It is dry-mixed（Dry process）：（4）Multi-vitamins, composite mineral matter, glutamine are uniformly mixed with material C to get production
Product.
3. a kind of preparation method of Low lactose milk formula powder according to claim 2, it is characterised in that the step（1）In
Stabilizer is selected from the potassium citrate of 1.0%-2.5%, and the percentage is the mass percent of Low lactose milk formula powder total mass of raw material.
4. a kind of preparation method of Low lactose milk formula powder according to claim 2, it is characterised in that the step（2）In
Emulsifier and its weight be selected from starch Sodium Octenyl Succinate 0.1%-1.5% or list diglycerol acid aliphatic ester 0.1%-1.5% or
Citric acid fatty glyceride 0.1%-1.5%, the percentage are the mass percent of Low lactose milk formula powder total mass of raw material.
5. a kind of preparation method of Low lactose milk formula powder according to claim 2, it is characterised in that the step（3）In
Sterilization conditions are 68 DEG C -70 DEG C of temperature, time 20-40min；Spray drying condition is 160 DEG C -210 DEG C of inlet air temperature, air draft temperature
66 DEG C -95 DEG C of degree.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810620775.7A CN108902990A (en) | 2018-06-15 | 2018-06-15 | A kind of Low lactose milk formula powder and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810620775.7A CN108902990A (en) | 2018-06-15 | 2018-06-15 | A kind of Low lactose milk formula powder and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108902990A true CN108902990A (en) | 2018-11-30 |
Family
ID=64421076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810620775.7A Pending CN108902990A (en) | 2018-06-15 | 2018-06-15 | A kind of Low lactose milk formula powder and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108902990A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116138438A (en) * | 2023-04-19 | 2023-05-23 | 益欣汇盛科技(北京)有限公司 | Oil-in-water submicron emulsion system and preparation method and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102422900A (en) * | 2011-11-24 | 2012-04-25 | 黑龙江飞鹤乳业有限公司 | Formula milk powder for promoting absorption of fatty acid and calcium and preparation method thereof |
| CN108142562A (en) * | 2018-03-06 | 2018-06-12 | 青岛金大洋乳业有限公司 | A kind of formula powder and preparation method of the oral immunological tolerance of induction moderately hydrolyzed |
-
2018
- 2018-06-15 CN CN201810620775.7A patent/CN108902990A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102422900A (en) * | 2011-11-24 | 2012-04-25 | 黑龙江飞鹤乳业有限公司 | Formula milk powder for promoting absorption of fatty acid and calcium and preparation method thereof |
| CN108142562A (en) * | 2018-03-06 | 2018-06-12 | 青岛金大洋乳业有限公司 | A kind of formula powder and preparation method of the oral immunological tolerance of induction moderately hydrolyzed |
Non-Patent Citations (1)
| Title |
|---|
| 蒋朱明等: "《临床肠外与肠内营养》", 30 April 2010, 科学技术出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116138438A (en) * | 2023-04-19 | 2023-05-23 | 益欣汇盛科技(北京)有限公司 | Oil-in-water submicron emulsion system and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2749672C2 (en) | Composition of lipids for use in infants and young children, promoting intestinal comfort and optimal absorption of fat and calcium | |
| CN112535283A (en) | Total nutrient formula powder | |
| CN102283288A (en) | Infant formula goat milk powder added with structural grease and preparation method thereof | |
| CN103458889A (en) | Nutritional compositions including branched chain fatty acids for wound healing | |
| CN109275729B (en) | Compound grease simulating breast milk fatty acid, infant formula goat milk powder containing compound grease and preparation method of infant formula goat milk powder | |
| US20240108050A1 (en) | Infant nutrition with hydrolysed protein, ionic calcium and palmitic acid | |
| CN104920618A (en) | Formula goat milk powder for pregnant and lying-in woman | |
| Park | Goat milk and human nutrition | |
| CN107712050A (en) | One kind addition sialic acid and digestible premature labor baby milk powder and preparation method thereof | |
| CN105994680A (en) | Infant formula goat milk powder and preparation method thereof | |
| CN110881526A (en) | Composition for promoting iron absorption and application thereof | |
| CN105831253A (en) | Lactose-free infant formula milk powder and preparation method thereof | |
| CN109077123A (en) | A kind of infant formula goat milk powder produced using concentrating and desalinating sheep whey liquid | |
| Pampaloni et al. | Parmigiano Reggiano cheese and bone health | |
| CN108902990A (en) | A kind of Low lactose milk formula powder and preparation method thereof | |
| KR101356926B1 (en) | Goat milk infant formula comprising humanized protein composition for improved digestibility | |
| CN108741103A (en) | A kind of flu phase small peptide formula powder of strengthen immunity and preparation method thereof | |
| RU2703172C2 (en) | Feeding for infants with hydrolysed protein and palmitic acid | |
| CN101816340B (en) | Defatted and desugared nutritional formula milk powder and preparation method thereof | |
| KR101249082B1 (en) | Infant formula containing hydrolyzed whey powder, hydrolyzed skin milk powder preparation and β-casein | |
| US20240032554A1 (en) | Novel process for preparing an isolate of cationic whey proteins and the product thus obtained | |
| CN108902956A (en) | A kind of amino acid formula powder and preparation method thereof | |
| CN113840541A (en) | Dietary butyrate and uses thereof | |
| CN111194914A (en) | Infant formula food and preparation method thereof | |
| RU2791491C1 (en) | Specialized low-fat product based on whole milk protein for feeding infants from birth |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20181130 |
|
| WD01 | Invention patent application deemed withdrawn after publication |